CMG heads into Thursday's Q2 print with the Street freshly split and options traders now running their most hedged posture of the past year.
The options picture has grown more acute since the Morgan Stanley downgrade earlier this week. The put/call ratio has climbed to 1.15 — nearly 2.7 standard deviations above its 20-day mean of 1.00, and the closest it has been to its 52-week high of 1.19 in months. That is an unusually concentrated demand for downside protection, and it has arrived in the same week the stock bounced 4.1% on Friday after shedding 7.9% over the prior week. Short interest, at 3.2% of the free float, tells a much calmer story: it has eased roughly 6% over the past month and the borrow market remains extraordinarily loose, with availability effectively uncapped. There is no squeeze dynamic at play here — the defensiveness is coming entirely from options, not from short sellers.
The analyst picture entering this print is unusually conflicted. Just before the close of last week, JP Morgan's John Ivankoe upgraded CMG to Overweight while simultaneously cutting his target from $38 to $35 — a buy call on a stock he is now less optimistic about in absolute terms, but which he apparently sees as oversold at current levels. That upgrade arrives days after Morgan Stanley's Brian Harbour cut to Equal-Weight from Overweight with a target of $37, down from $49. The two moves together capture the debate: one bellwether firm thinks the valuation reset has gone far enough; another thinks the growth premium still has further to compress. The consensus sits at hold, with a mean target of $42.88 — implying roughly 46% upside from the current $29.34, though that gap partly reflects how abruptly the stock has de-rated relative to where analyst models were anchored. Bulls point to forward EPS growth running well above peers, a five-year EBIT CAGR near 20%, and a quality score at multi-year highs. Bears argue that the fresh-ingredient premium is increasingly difficult to reconcile with pricing strategy, that comp growth has been inconsistent, and that at a P/E of 23.9x, the stock still commands a multiple that requires execution the company has not always delivered.
Peers offer limited comfort. SG — Sweetgreen — fell 25.5% on the week, a far steeper drop than CMG's own 7.9% slide, suggesting sector-wide fast-casual pressure rather than a company-specific story. WING dropped 9.4% over the same stretch, while BJRI lost 8.5%. The one outlier was CAKE, which was flat week-on-week, hinting that more value-oriented casual dining is holding up better than growth-priced names. The last two CMG earnings prints produced a modest 3.4% one-day gain on the April 2026 report and a slight 0.8% decline on the prior quarter — neither a dramatic reaction. The June 11 print will test whether the Street's new, lower anchor for Chipotle's growth premium is finally in the price, or whether the debate between Ivankoe and Harbour needs another data point to resolve.
See the live data behind this article on ORTEX.
Open CMG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
